• Philippe Goutorbe, Erwan Daranda, Yves Asencio, Pierre Esnault, Bertrand Prunet, Julien Bordes, Bruno Palmier, and Eric Meaudre.
• Emergency, Anesthesia and ICU Departement, Military Teaching Hospital Sainte Anne, Boulevard Sainte Anne, Toulon 83000, France. goutorbephil@live.fr
• BMC Res Notes. 2013 Jan 1; 6: 282.

BackgroundLong term oxygen therapy improves survival in hypoxemic patients with chronic obstructive pulmonary disease (COPD). Because pressure support ventilation with a home care ventilator is largely unsupervised, there is considerable risk of leakage occurring, which could affect delivered FiO2. We have therefore conducted a bench study in order to measure the effect of different levels of O2 supply and degrees of leakage on delivered FiO2. Ventilator tested: Legendair® (Airox™, Pau, France). Thirty-six measures were performed in each four ventilators with zero, 5 and 10 l.min-1 leakage and 1,2,4 and 8 l O2 flow.FindingsFiO2 decreased significantly with 5 l.min-1 leakage for all O2 flow rates, and with 10 l.min-1 at 4 and 8 l.min-1 O2.ConclusionDuring application of NIV on home ventilators, leakage can dramatically decrease inspired FiO2 making it less effective. It is important to know the FiO2 dispensed when NIV is used for COPD at home. We would encourage industry to develop methods for FiO2 regulation Chronic use of NIV for COPD with controlled FiO2 or SpO2 requires further studys.

7 keywords...

hide…